The European Cancer Organization has just launched its “Data Navigator”, a new interactive visualization tool providing access to data on the impact of Covid-19 on cancer treatment and screening in Europe. According to data collected by this cancer-fighting organization in Europe, covid-19 has seriously affected cancer screening and treatment in 17 European countries. “While Covid-19 has revealed significant failures in our health systems, its general impact on cancer care in Europe remains unknown to this day. It is for this reason that we have developed an easy-to-use tool. use that will assess the challenges and inequalities that European countries have faced in the provision of care during the pandemic “insists Mark Lawyer, who participated in the development of this tool within the European cancer organization.
A disastrous impact on patients with covid-19
- About 100 million screening tests failed
- A million cancers may have gone undiagnosed
- In France, a delay of about 200 days has been accumulated in chemotherapy treatments
- The number of cancers diagnosed in April 2020 fell by 42% compared to April 2019
“The Data Navigator provides further demonstration of the extent of the consequences of Covid-19 on the fight against cancer and on cancer care across Europe, highlighting the need for urgent action to catch up with the delays in care and rebuilding more resilient health systems “says Matti Aapro, president of the European Cancer Organization.
Read also :
- Cancer drugs: why are the shortages getting worse?
- Covid-19: there will be an increased excess mortality at 5 years